Editor's take: The week that was — Jan 2-7
Here is the first weekly wrap-up of 2023.
Source: dealstreetasia.com
Stay updated with breaking news from Bioray Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Here is the first weekly wrap-up of 2023.
An Asian sovereign wealth fund and state-owned investment firm participated in the deal.
Milestone Payment is the Second of Four in $5M Pritumumab Licensing DealVERO BEACH, FL / ACCESSWIRE / February 23, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company")